Alcon sees 2020 dividend, bolt-on purchases in life after Novartis

Alcon, which made the announcement on Tuesday ahead of an investor day in New York, is being jettisoned from Novartis’s portfolio as Chief Executive Vas Narasimhan focuses on new drugs, not the surgical devices and contact lenses that Alcon makes.

Original source:

Related Posts